Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
News

Tolero Pharmaceuticals doses first patient in Phase II Zella 202 study

Close
Close
Close

Go Top